The Scientist - Home

A pill is shown on a blue technical background. One half of the pill has a DNA helix on it, and the other half has a depiction of a computer chip, representing the role of artificial intelligence in drug development.
| 3 min read
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.

Latest

The Scientist Placeholder Image

Top Scientists Send Nuclear Test Ban Plea To Bush, Yeltsin

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

Bush Gives National Medals To Merck, 15 Researchers

The Scientist Placeholder Image

Fetal Tissue Research Uncertainties Foster Confusion Among Many Bioscience Workers

The Scientist Placeholder Image

U.S. Scientists Wary Of Traveling To China

The Scientist Placeholder Image

Rio Document Spurs Debate: Is Science An Ecological Foe?

The Scientist Placeholder Image

Star Wars Laser Makes Its Move Into Biomedical Research

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

U. Delaware Reaches Accord On Race Studies

The Scientist Placeholder Image

Lawsuit Spurs Debate Over PCAST Meetings: Should They Be Open To Press And Public?

The Scientist Placeholder Image

Honor Society Sigma Xi Strives To Bolster Image And Membership

The Scientist Placeholder Image

NRC Project Aims To Change Early Science Education

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies